Therapeutic Drug Monitoring of Infliximab in Acute Severe Ulcerative Colitis

Therapeutic drug monitoring (TDM) is a useful strategy in ulcerative colitis (UC). Nearly a quarter of UC patients will experience acute severe UC (ASUC) in their lifetime, including 30% who will fail first-line corticosteroid therapy. Steroid-refractory ASUC patients require salvage therapy with in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Benjamin L., Battat, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219098/
https://www.ncbi.nlm.nih.gov/pubmed/37240484
http://dx.doi.org/10.3390/jcm12103378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219098/
https://www.ncbi.nlm.nih.gov/pubmed/37240484
http://dx.doi.org/10.3390/jcm12103378

Ejemplares similares